Target intelligence / Profile preview

Ribosomal protein L27 pseudogene 12 (RPL27P12)

Target
RPL27P12
Molecular classification
Other (Pseudogene)
01

Overview

RPL27P12 (ribosomal protein L27 pseudogene 12) is a processed pseudogene in the human genome related to the ribosomal protein L27 gene (RPL27). Unlike its parent gene, RPL27P12 does not code for an active ribosomal protein; its sequence is similar in structure but contains disabling mutations that render it non-functional. Like other ribosomal pseudogenes, it has arisen through retrotransposition but is simply a remnant of the protein-coding gene with no current role in protein synthesis or other cellular functions[2][3]. Pseudogenes of ribosomal proteins are frequent in the human genome and are neither expressed nor capable of producing functional proteins[2][3]. RPL27P12 is a pseudogene, not a therapeutic target, and does not participate in any known molecular pathways or diseases. All entries on interacting drugs, function, or disease relevance should be considered null. If a functional ribosomal protein L27 is desired—refer to RPL27, not its pseudogene relatives such as RPL27P12[1][6].

Other names
RPL27_4_1293RPL27P12
02

Biological functions

Other (No protein produced; no known biological function)
03

Disease associations

Other (No established role in disease as a pseudogene)

Beyond the preview

Go deeper on Ribosomal protein L27 pseudogene 12 (RPL27P12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L27 pseudogene 12 (RPL27P12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call